DK149823C - Fremgangsmaade til fremstilling af kijanimicin eller farmaceutisk acceptable salte heraf - Google Patents

Fremgangsmaade til fremstilling af kijanimicin eller farmaceutisk acceptable salte heraf

Info

Publication number
DK149823C
DK149823C DK12581A DK12581A DK149823C DK 149823 C DK149823 C DK 149823C DK 12581 A DK12581 A DK 12581A DK 12581 A DK12581 A DK 12581A DK 149823 C DK149823 C DK 149823C
Authority
DK
Denmark
Prior art keywords
kijanimicin
procedure
preparation
acceptable salts
pharmaceutical acceptable
Prior art date
Application number
DK12581A
Other languages
Danish (da)
English (en)
Other versions
DK149823B (da
DK12581A (da
Inventor
Jay Allan Waitz
Ann Camille Horan
Mahesh Gordhandas Patel
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of DK12581A publication Critical patent/DK12581A/da
Publication of DK149823B publication Critical patent/DK149823B/da
Application granted granted Critical
Publication of DK149823C publication Critical patent/DK149823C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/03Actinomadura
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK12581A 1980-01-17 1981-01-13 Fremgangsmaade til fremstilling af kijanimicin eller farmaceutisk acceptable salte heraf DK149823C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11276080A 1980-01-17 1980-01-17
US11276080 1980-01-17
US06/195,048 US4375542A (en) 1980-01-17 1980-10-08 Kijanimicin antibiotics and derivatives thereof
US19504880 1980-10-08

Publications (3)

Publication Number Publication Date
DK12581A DK12581A (da) 1981-07-18
DK149823B DK149823B (da) 1986-10-06
DK149823C true DK149823C (da) 1987-03-16

Family

ID=26810312

Family Applications (1)

Application Number Title Priority Date Filing Date
DK12581A DK149823C (da) 1980-01-17 1981-01-13 Fremgangsmaade til fremstilling af kijanimicin eller farmaceutisk acceptable salte heraf

Country Status (20)

Country Link
US (1) US4375542A (de)
EP (1) EP0033840B1 (de)
JP (1) JPS56118078A (de)
KR (1) KR840000751B1 (de)
AR (1) AR226337A1 (de)
AT (1) ATE8798T1 (de)
AU (1) AU543520B2 (de)
CA (1) CA1177426A (de)
DE (1) DE3164568D1 (de)
DK (1) DK149823C (de)
ES (1) ES8200922A1 (de)
FI (1) FI69099C (de)
HU (1) HU181799B (de)
IE (1) IE50810B1 (de)
IL (1) IL61902A (de)
NO (1) NO155732C (de)
NZ (1) NZ196006A (de)
PH (1) PH17057A (de)
PT (1) PT72348B (de)
ZA (1) ZA81217B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4983525A (en) * 1987-07-02 1991-01-08 American Cyanamid Company Plasmids derived from actinomadura species
US5753701A (en) * 1996-10-25 1998-05-19 University Of Kentucky N-chloro-N-methyl glucamine and N-chloro-N-methyl glucamine esters as novel safe agents for water disinfection
WO2000012494A1 (fr) 1998-08-31 2000-03-09 Kyowa Hakko Kogyo Co., Ltd. Agents induisant l'apoptose
ATE410423T1 (de) * 2000-04-26 2008-10-15 Zaidan Hojin Biseibutsu Gemische zur behandlung oder prävention von malaria und verfahren zur behandlung von malaria
AU2002330374A1 (en) 2001-11-22 2003-06-10 Kazuo Shinya Novel tetronic acid dervative
US8754054B2 (en) * 2010-07-09 2014-06-17 Albany Molecular Research, Inc. Antibacterial compounds, methods of making them, and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3364113A (en) * 1962-04-23 1968-01-16 Westminster Lab Ltd Senna preparations and methods of making and using them
FR1530409A (fr) * 1963-08-28 1968-06-28 Nouveaux dérivés de l'asiaticoside et leur procédé de préparation
US3723410A (en) * 1970-12-01 1973-03-27 Amazon Natural Drug Co Method of producing stevioside
JPS51142570A (en) * 1975-06-04 1976-12-08 Morita Kagaku Kogyo Method of imparting sweetness to food or pharmaceutical agent

Also Published As

Publication number Publication date
US4375542A (en) 1983-03-01
IL61902A (en) 1984-10-31
ES498452A0 (es) 1981-11-16
FI69099C (fi) 1985-12-10
EP0033840A2 (de) 1981-08-19
EP0033840B1 (de) 1984-08-01
HU181799B (en) 1983-11-28
FI69099B (fi) 1985-08-30
JPH0327559B2 (de) 1991-04-16
DE3164568D1 (en) 1984-09-06
ATE8798T1 (de) 1984-08-15
NZ196006A (en) 1983-09-02
PT72348A (en) 1981-02-01
FI810078L (fi) 1981-07-18
KR840000751B1 (ko) 1984-05-31
DK149823B (da) 1986-10-06
EP0033840A3 (en) 1981-12-02
NO155732B (no) 1987-02-09
IL61902A0 (en) 1981-02-27
PH17057A (en) 1984-05-17
ES8200922A1 (es) 1981-11-16
NO810114L (no) 1981-07-20
DK12581A (da) 1981-07-18
AU543520B2 (en) 1985-04-26
CA1177426A (en) 1984-11-06
KR830005360A (ko) 1983-08-13
IE50810B1 (en) 1986-07-23
JPS56118078A (en) 1981-09-16
AR226337A1 (es) 1982-06-30
NO155732C (no) 1987-05-20
IE810054L (en) 1981-07-17
PT72348B (en) 1981-12-18
ZA81217B (en) 1982-01-27
AU6619181A (en) 1981-07-23

Similar Documents

Publication Publication Date Title
DK146482A (da) Fremgangsmaade til fremstilling af cyklobutylaminderivater eller farmaceutisk acceptable salte deraf
DK160940C (da) Analogifremgangsmaade til fremstilling af benzoheterocycliske forbindelser eller farmaceutisk acceptable salte deraf
DK552581A (da) Fremgangsmaade til fremstilling af 3-pyridylaklyl-indol-forbindelser eller farmaceutisk acceptable salte deraf
DK152114C (da) Analogifremgangsmaade til fremstilling af propenylaminer eller farmaceutisk acceptable salte deraf
DK161968C (da) Analogifremgangsmaade til fremstilling af imidazo-pyrazolo-pyrimidiner eller farmaceutisk acceptable salte deraf
DK503080A (da) Fremgangsmaade til fremstilling af imdazolderivater eller salte deraf
DK273479A (da) Fremgangsmaade til fremstilling af 5-phenylpyrazol-forbindelser eller salte deraf
DK70083D0 (da) Fremgangsmade til fremstilling af pyrroleddikesyreamider eller salte deraf
DK149856C (da) Fremgangsmaade til fremstilling af 1,3-di- eller 1,3,8-trisubstituerede xanthiner eller fysiologisk acceptable salte deraf
DK159427C (da) Analogifremgangsmaade til fremstilling af antiallergisk virksomme quinolinonderivater eller salte deraf
DK158658C (da) Analogifremgangsmaade til fremstilling af 9-aminoalkylfluorener eller farmaceutisk acceptable salte deraf
DK161699C (da) Analogifremgangsmaade til fremstilling af 4-aryl-4-piperidincarbinoler eller farmaceutisk acceptable salte deraf
DK324979A (da) Fremgangsmaade til fremstilling af imidazoquinoxaliner eller salte deraf
DK358183A (da) Fremgangsmaade til fremstilling af alfa-aryl-alkansyrer eller salte deraf
DK232777A (da) Fremgangsmade til fremstilling af imidazothiaziner eller farmaceutisk acceptable salte deraf
DK232677A (da) Fremgangsmade til fremstilling af dihydro eller tetrahydroiminothiaziner eller farmaceutisk acceptable salte deraf
DK232877A (da) Fremgangsmade til fremstilling af 2-imino-3-aminothiazolidiner eller farmaceutisk acceptable salte deraf
DK152491C (da) Analogifremgangsmaade til fremstilling af esterholdige phenoxypropanolaminer eller farmaceutisk anvendelige salte deraf
DK149823C (da) Fremgangsmaade til fremstilling af kijanimicin eller farmaceutisk acceptable salte heraf
DK165983C (da) Fremgangsmaade til fremstilling af phosphorholdige antibiotiske forbindelser betegnet cl 1565-a, cl 1565-b og cl 1565-t eller farmaceutisk acceptable salte deraf
DK115379A (da) Fremgangsmaade til fremstilling af dilignoler eller dilignollignende forbindelser eller salte heraf
DK224381A (da) Fremgangsmaade til fremstilling af benzazolderivater eller salte deraf
DK150521C (da) Analogifremgangsmaade til fremstilling af n2-arylsulfonyl-l-argininamider eller farmaceutisk acceptable salte deraf
DK210183A (da) Fremgangsmaade til fremstilling af piperidinoquinazolin-forbindelser eller farmaceutisk acceptable salte deraf
DK476082A (da) Fremgangsmaade til fremstilling af phenolderivater eller salte deraf

Legal Events

Date Code Title Description
PBP Patent lapsed